logo
episode-header-image
Jul 2022
27m 52s

Immunai CTO and Co-Founder Luis Voloch o...

Nvidia
About this episode
What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI technology to map the human immune system and speed the development of new imm ... Show More
Up next
Yesterday
How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies ... Show More
31m 40s
Jul 2
Alembic and the Future of AI in Marketing - Ep. 263
Tomás Puig, founder and CEO of Alembic, joins the NVIDIA AI Podcast to discuss the intersection of AI, data, and marketing. He shares how Alembic uses advanced mathematics and AI—particularly spiking neural networks and causal inference—to help brands extract actionable insights ... Show More
39m 44s
Jun 25
Hippocratic AI's Munjal Shah on How AI Agents Are Expanding Healthcare Capacity - Ep. 262
Munjal Shah, CEO of Hippocratic AI, discusses how AI agents can dramatically expand healthcare capacity and access. With 1.8 million patient calls completed and an 8.95/10 satisfaction rating, Hippocratic's safety-focused LLM demonstrates how optimized AI inference can handle rou ... Show More
21m 49s
Recommended Episodes
Jan 2018
Immune 4: Putting the immunotherapy CAR T before the cancer
The immu-knowledge-ists deconstruct the holy grail of oncologists, cancer immunotherapy, and the exciting development of CAR T cells and how they work. Hosts: Vincent Racaniello, Stephanie Langel, and Cynthia Leifer Become a patron of Immune! Links for this episode Synthetic Immu ... Show More
1h 23m
Dec 2022
HIBT Lab! Immunai: Noam Solomon
According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop ... Show More
33m 37s
Mar 2023
How to build a virus-proof cell
00:47 An edited genetic code that prevents viral infectionResearchers have engineered bacteria with synthetic genomes to be immune to viral infection. The team streamlined the bacteria’s genetic code, and re-engineered the protein-producing machinery to insert the wrong amino aci ... Show More
31m 38s
May 2021
Robot revolution
A brain-computer interface allows a severely paralysed patient not only to move and use a robotic arm, but also to feel the sensations as the mechanical hand clasps objects . We hear from Jennifer Collinger at Pittsburgh University’s Rehab Neural Engineering Labs. And Nathan Cope ... Show More
36m 17s
Mar 2024
From Single Neurons to AI Systems: The Evolution of Decision Sciences in Medicine with Dr. Eric Horvitz
In this episode of the AI Grand Rounds podcast, Dr. Eric Horvitz describes his career evolution from an interest in neurobiology to significant contributions in AI, particularly in understanding complex systems and applying AI in medicine. He discusses the shift from studying neu ... Show More
1h 7m
Dec 2020
The Challenges of Bringing AI into the Pharmaceutical Industry - with Kristof Szalay of Turbine.AI
Today's guest is the great and brilliant Dr. Kristof Szalay, CTO and Founder of Turbine.AI. Turbine's AI-driven platform understands cancer's inner mechanisms, enabling the discovery of novel targets & precision medicinal therapies. Episode topics include: dynamics of pharmaceuti ... Show More
17m 42s
Jul 2023
Immune 70: Immunology of picky eating
Immune explains how mast cells, IgE antibody, and the brain collaborate to promote avoidance of certain foods to evade allergic responses. Hosts: Vincent Racaniello, Cynthia Leifer, and Brianne Barker Subscribe (free): Apple Podcasts, Google Podcasts. RSS, email Become a patron o ... Show More
1h 7m
May 2024
Grant Mitchell — The Potential of AI Drug Repurposing
Grant Mitchell is a seasoned entrepreneur, operator, and investor in the areas of health, technology, and machine learning. He is currently the co-founder and CEO of Every Cure, where he uses AI to research rare diseases and conduct drug repurposing. Grant joins the show to discu ... Show More
1h 5m
Mar 2023
The ‘Mini Brains’ solving medical mysteries and raising concerns
It may seem like science fiction, but over the past decade scientists have been using stem cells to grow so-called “mini brains.” Researchers prefer the term brain organoids, a collection of human cells in a petri dish that mimic the structure and cell types of our own brains. Th ... Show More
24m 36s